Filter Results:
(232)
Show Results For
- All HBS Web
(1,022)
- People (4)
- News (232)
- Research (615)
- Events (9)
- Multimedia (24)
- Faculty Publications (396)
Show Results For
- All HBS Web
(1,022)
- People (4)
- News (232)
- Research (615)
- Events (9)
- Multimedia (24)
- Faculty Publications (396)
Sort by
- 01 Jun 2023
- News
Research Brief: The Best Medicine
only about 5 percent of participants in clinical drug trials. In the working paper, “Representation and Extrapolation: Evidence from Clinical Trials,” coauthors Marcella Alsan, Maya Durvasula, Harsh Gupta, Heidi Williams, and... View Details
- 01 Jun 2000
- News
The Business of Biotech
biotechnology. The prospect is exhilarating, but the road to this brave new biotech world has more than a few bumps. With an average time line of ten years required to bring a drug to market - and the potential for failure looming every... View Details
Keywords: Julia Hanna
- 15 Dec 2024
- News
After Ozempic
affiliate in Plainsboro, New Jersey. That all changed when its breakthrough drug for type 2 diabetes, Ozempic, hit the market in 2018. By some biochemical mystery, it also turned out to be a powerful tool for weight loss—which led to the... View Details
- 01 Jan 2009
- News
Kathryn E. Giusti, MBA 1985
aided in the development of drugs for this and other cancers. A successful marketing executive who had worked at Merck, Gillette, and Searle, Giusti was diagnosed with myeloma in 1996. As she faced a grim prognosis of three years to live,... View Details
- 01 Dec 2017
- News
2017 in Health Care: Telemedicine Has Arrived
telemedicine services available next year to employees in states that allow it. We’re going to see a lot more investment in this area, from both established health care companies and startups. What’s next in health care? “More constraints on View Details
- 14 May 2014
- News
(Re)moving the Needle
You wouldn't think that the lowly, annoying mosquito would have anything to teach researchers working on the cutting edge of drug delivery methodology, but you would be wrong. Have you ever noticed that you don't become aware of a... View Details
- 05 May 2020
- News
“Walking a Tightrope”
Kristof, most of which have focused on poverty in developing countries. But in the Pulitzer Prize-winning duo’s latest book, Tightrope: Americans Reaching for Hope, they turn their lens on working class communities in the United States—communities that have been... View Details
- 22 Sep 2017
- News
The Epicenter of Miami’s Vice
PBS Hour dug deep into the scene's underworld and found that all roads lead to the Mutiny, this glitzy hotel in Coconut Grove that was a hub for celebrities and the epicenter of a global drug trade. Farzad spoke with the Bulletin's... View Details
- 01 Dec 2022
- News
Road to Recovery
illegal-drug addictions totaled an estimated $700 billion in direct and indirect costs, according to a 2015 report from the National Institute on Drug Abuse. DynamiCare developed an app that provides financial rewards via a debit card... View Details
- 24 Apr 2014
- News
Building a better India through business and philanthropy
more than 30 countries, Mumbai-based Piramal Group comprises companies focused on health care, life sciences, drug discovery, health care information management, financial services, specialty-glass packaging, and real estate. Recently,... View Details
- 11 May 2021
- News
Pitching to Win
the five grand-prize winners. Goble is co-founder of Karivez Bio, a platform for transforming chronic disease treatment through improved drug delivery. Okrah is founder and CEO of Chaku Foods, a fast-moving consumer goods company based in... View Details
- 25 Apr 2014
- News
Disrupting criminal enterprises that prey on children
Kayla Brochu (MBA/JD 1999) deployed business and legal strategies to combat some of the world's worst crimes as the United Nations Office on Drugs and Crime Expert on Technology-Facilitated Child Abuse, Exploitation, and Trafficking.... View Details
- 16 Sep 2016
- News
Gaining Ground on ALS
Bucket Challenge to support the Phase 3 trial of a promising investigational drug that is designed to slow the loss of lung function and muscle strength in patients with ALS. “Clinical trials cost tens to hundreds of millions of dollars,”... View Details
- 04 Sep 2019
- News
Accelerating Scientific Discovery
reduce human disease and suffering influences his work as a health care economist and researcher. “I imagine a world where we have treatments, ideally cures, for diseases where right now we have nothing,” he says. “So the big questions that motivate me are, what are... View Details
Keywords: Jennifer Gillespie
- 01 Sep 2008
- News
In Africa, Porter Sees Lessons for Health Care
delivery systems of both developing and advanced countries: fragmentation, inefficiency, and organization around discrete interventions (such as delivering drugs or screening) rather than integrated care. Porter and his colleagues aim to... View Details
- 01 Jun 2018
- News
Floor It
case study with the Multiple Myeloma Research Foundation, GNS Healthcare, the Moffitt Cancer Center’s ORIEN program, and biotech firm Foundation Medicine. Rethinking Drug Trials In an adaptive platform trial, different View Details
Keywords: Julia Hanna; illustration by Mengxin Li
- 01 Sep 2004
- News
American Dream
visitors in their tracks. “I wonder if I should turn him down a little,” Hustead muses. As president of Wall Drug in Wall, South Dakota, Hustead ponders this and many other details of a 76,000-square-foot roadside attraction, not far from... View Details
- 30 Sep 2022
- News
Scaling Hope
collection of essays that D’Antonio hopes will help other parents, he writes of what he wishes he’d known in the beginning: “I wish I had known that there was hope, a lot of hope, and that recovery was likely to happen for my son. I wish I had known that my son could... View Details
- 01 Mar 2008
- News
The Last Frontier
state for people with debilitating but nonterminal diseases like his to receive, with a doctor’s assistance, drugs with which they may take their own lives. Explained Gardner, “Why do this? I want to be involved in public life. I was... View Details
- 24 Apr 2014
- News
Finding a cure so that others may benefit
call. The foundation wanted to invest in for-profit bioscience companies to spur scientists to find a cure for the disease. O’Donnell is credited with almost singlehandedly raising $250 million in support of this venture philanthropy, which led to the development of... View Details